Lexington Biosciences, Inc. is a medical device company, which engages in the research and development of non-diagnostic devices. Its products include HeartSentry, a non-invasive diagnostic device that measure and monitor cardiovascular health by assessing the function of a person's vascular endothelium. The company was founded on April 12, 2016 and is headquartered in Vancouver, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company